Today: 3 June 2026
Kyndryl stock price steadies in premarket after 55% crash on SEC-linked review and delayed filing
10 February 2026
2 mins read

Kyndryl stock price steadies in premarket after 55% crash on SEC-linked review and delayed filing

New York, Feb 10, 2026, 04:53 ET — Premarket

  • KD shares edged up 0.4% in premarket trading, a slight rebound after plunging nearly 55% on Monday.
  • Kyndryl has delayed its quarterly report and flagged internal-control weaknesses, the company said in an SEC notice.
  • The delayed 10-Q remains in focus, with traders looking for specifics on the remediation plan and any timeline updates.

Kyndryl Holdings (KD) edged up 0.4% to $10.63 in premarket trade Tuesday. The move followed a brutal prior session that saw the stock plunge 54.9%, ending at $10.59. Volume exploded Monday, with roughly 61 million shares trading hands—well above normal.

Kyndryl, in a Form 12b-25 filed with the SEC, said it will need extra time to complete its quarterly Form 10-Q covering the period ended Dec. 31. The company disclosed that its audit committee is examining cash-management practices and related disclosures—this includes what’s behind its adjusted free cash flow figure—after receiving voluntary document requests from the SEC’s Division of Enforcement. Kyndryl also signaled it expects to report “material weaknesses” in internal controls, mentioning concerns tied to “tone at the top.” On top of that, it said investors shouldn’t rely on its previous internal-control assessment or PricewaterhouseCoopers’ opinion on fiscal 2025.

It’s a tough mix for investors. They’re staring at both shaky-looking numbers and questions around disclosure timing. A company might claim no restatement is coming, but wording on controls like this usually pushes investors to consider a wider set of possible outcomes.

With a management shake-up underway, Kyndryl revealed finance chief David Wyshner’s exit and Vineet Khurana’s resignation as global controller. The company tapped Harsh Chugh for interim CFO and Bhavna Doegar for interim corporate controller roles, but wouldn’t comment on whether these moves connect to its ongoing review. J.P. Morgan slashed its rating on the stock to “underweight,” describing the CFO’s departure as “stunning” and cautioning that the updated guidance could stall Kyndryl’s turnaround, according to Reuters. Reuters

Kyndryl, spun off from IBM back in 2021, posted quarterly revenue of $3.86 billion for the period ending Dec. 31—a 3% increase over the same stretch last year. Adjusted earnings landed at 52 cents a share. For its fiscal 2026, management tweaked guidance: They’re now calling for a 2% to 3% drop in constant-currency revenue (that’s after taking out currency effects), and they see free cash flow in the $325 million to $375 million range. In the quarter, revenue from hyperscaler alliances jumped 58% to $500 million. “Our signings continue to reflect the vital role we play in customers’ technology estates,” CEO Martin Schroeter said in the release.

Kyndryl shares have dropped to the point where the stock’s trading less as a pure IT-services play and more as a governance situation. Cloud migration and AI services have become the sector’s main pitch. Kyndryl, for its part, keeps highlighting expansion in consulting and partnerships—territory dominated by giants like Accenture and IBM.

Near-term headaches aren’t just theoretical. When a company’s quarterly filing is late, certain institutions may back away, which has an immediate effect on what they’ll hold—and that alone can keep borrowing costs elevated, regardless of whether regulators step in publicly.

The risk here is clear enough: should the audit-committee review widen, or if pressure on cash-flow disclosures means Kyndryl has to adjust how it reports non-GAAP metrics, investors could turn even more cautious. There’s also the chance Kyndryl delays its filing longer than anticipated, which would leave the stock moving on incomplete data.

Traders have their eyes on one thing this Tuesday: Kyndryl’s overdue Form 10-Q for the December quarter. The company has promised details on a remediation plan in the filing, and investors are holding out for more specifics on when the review will finally wrap up.

Latest articles

Archer Aviation trades under $7 as next test looms for air-taxi gamble

Archer Aviation trades under $7 as next test looms for air-taxi gamble

3 June 2026
Archer Aviation shares dipped below $7 premarket after closing at $6.74, as investors weigh heavy cash burn—$217.7 million Q1 net loss, $1.78 billion cash on hand—against hopes for first U.S. eVTOL flights this year; Cantor Fitzgerald cut its price target to $11 but kept an Overweight rating, while 46 disclosed risks and ongoing certification challenges cloud near-term outlook.
Broadcom’s $280 Billion AI Rally Hits Key Test

Broadcom’s $280 Billion AI Rally Hits Key Test

3 June 2026
Broadcom’s stock soared 14% in four days, adding $280 billion in value ahead of Wednesday’s earnings after Alphabet’s $80 billion equity raise spotlighted AI data-center suppliers; with options implying a 9% share move either way, investors await proof that surging AI demand is translating into real revenue growth.
J-Star Stock Moves Up After Texas Battery Update in Pre-Market

J-Star Stock Moves Up After Texas Battery Update in Pre-Market

3 June 2026
J-Star Holding Co. surged to $1.36 in premarket trading after new disclosures on its proposed $122.5 million Baytown, Texas solid-state battery plant, pushing shares above Nasdaq’s $1 minimum less than a week before a key shareholder vote on a reverse split aimed at regaining compliance.
Legend Biotech jumps 42% as traders look at results from small cancer study

Legend Biotech jumps 42% as traders look at results from small cancer study

3 June 2026
Legend Biotech shares soared 42% to $36.28 after early Phase 1 data showed all six higher-dose patients with relapsed or refractory B-cell non-Hodgkin lymphoma responded to its in vivo CAR-T therapy LB2501, with five complete responses; UBS raised its price target to $49, citing the therapy’s outlook, but the results are early and based on a small group with short follow-up.
T1 Energy Stock Falls Premarket After $32M KORE Battery Deal

T1 Energy Stock Falls Premarket After $32M KORE Battery Deal

3 June 2026
T1 Energy shares fell 1.3% premarket after announcing a $32 million KORE Power acquisition to expand into battery storage and AI data-center infrastructure, just a day after a 15.7% stock surge; Northland initiated coverage with an outperform rating and $16 target, but flagged deal execution and funding as key risks.
ICG plc stock slips in London after Asia-Pacific strategy hire lands
Previous Story

ICG plc stock slips in London after Asia-Pacific strategy hire lands

monday.com stock price: MNDY holds near $78 after guidance reset, 2027 targets shelved
Next Story

monday.com stock price: MNDY holds near $78 after guidance reset, 2027 targets shelved

Go toTop